2-11218994-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004850.5(ROCK2):c.1292C>A(p.Thr431Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.494 in 1,421,884 control chromosomes in the GnomAD database, including 179,796 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_004850.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROCK2 | NM_004850.5 | c.1292C>A | p.Thr431Asn | missense_variant | 10/33 | ENST00000315872.11 | NP_004841.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROCK2 | ENST00000315872.11 | c.1292C>A | p.Thr431Asn | missense_variant | 10/33 | 1 | NM_004850.5 | ENSP00000317985.6 |
Frequencies
GnomAD3 genomes AF: 0.456 AC: 69269AN: 151766Hom.: 17210 Cov.: 31
GnomAD3 exomes AF: 0.486 AC: 104885AN: 215796Hom.: 26339 AF XY: 0.487 AC XY: 57789AN XY: 118676
GnomAD4 exome AF: 0.498 AC: 632733AN: 1270000Hom.: 162575 Cov.: 21 AF XY: 0.498 AC XY: 316639AN XY: 635842
GnomAD4 genome AF: 0.456 AC: 69300AN: 151884Hom.: 17221 Cov.: 31 AF XY: 0.456 AC XY: 33863AN XY: 74210
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, variant associated with chronic kidney disease - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at